SCHEMBL16237215

SCHEMBL16237215

Cc1[nH]c(C(=O)Nc2cc(F)c(F)c(F)c2)cc1S(=O)(=O)Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.45
▸ ENPP2 Q13822 3/20 0.41
▸ LPAR1 Q92633 1/20 0.38
▸ PLA2G7 Q13093 11/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ PRNP P04156 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16236502 0.93 ENPP2 (0.40) CYP1A2ENPP2LPAR1PLA2G7NPC1
SCHEMBL16236829 0.92 CYP1A2 (0.41) CYP1A2ENPP2LPAR1PLA2G7NPC1
SCHEMBL16236925 0.89 CYP1A2 (0.36) CYP1A2ENPP2PLA2G7NPC1RAB9A
SCHEMBL16236340 0.88 ENPP2 (0.43) CYP1A2ENPP2LPAR1PLA2G7NPC1
SCHEMBL16237501 0.87 RAB9A (0.48) ENPP2PLA2G7NPC1RAB9AKDM4E
SCHEMBL16236610 0.84 NPC1 (0.49) PLA2G7NPC1RAB9AKDM4EALDH1A1
SCHEMBL16237029 0.81 CYP1A2 (0.41) CYP1A2PLA2G7NPC1RAB9AKDM4E
SCHEMBL16237209 0.80 PLA2G7 (0.45) PLA2G7NPC1RAB9ARXFP1
SCHEMBL16237133 0.80 PLA2G7 (0.36) PLA2G7NPC1RAB9AKDM4EALDH1A1
SCHEMBL16237067 0.80 GRM4 (0.41) PLA2G7NPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997011-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B Janssen Sciences Ireland UC (IE) 2016-03-23 — — EP disclosed
WO-2014184350-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN R&D IRELAND (IE) 2014-11-20 — — WO disclosed
Send feedback